CVI Holdings, LLC Buys NanoString Technologies Inc, Blueprint Medicines Corp, Axovant Gene Therapies, Sells MannKind Corp, Rexahn Pharmaceuticals Inc, Heat Biologics Inc

• New Purchases: NSTG, BPMC, EYPT, AGLE, TMDI, VTVT, OGEN, KOPN, MTNB, CODX, APVO, SOLO, MRSN, LQDA, CHMA, MBRX, PHIO, SHSP, IMV, ALRN, TRPX, ICCC, ACST, NVCN, FCEL,
• Added Positions: AXGT,
• Reduced Positions: MNKD, HTBX, VLRX, ADXS, VBLT, BBGI, AUG, NVIV, NOVN,
• Sold Out: RNN, VBIV, ARPO, CREG, SNOA, 44R2, AVGR, TNXP,

For the details of CVI Holdings, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/cvi+holdings%2C+llc/current-portfolio/portfolio

1. NanoString Technologies Inc (NSTG) - 774,068 shares, 25.72% of the total portfolio. New Position
2. Blueprint Medicines Corp (BPMC) - 200,000 shares, 22.23% of the total portfolio. New Position
3. Axovant Gene Therapies Ltd (AXGT) - 767,300 shares, 11.34% of the total portfolio. Shares added by 73.94%
4. Eros International PLC (EOITF) - 498,909 shares, 6.33% of the total portfolio. Shares added by 78.96%
5. EyePoint Pharmaceuticals Inc (EYPT) - 1,484,714 shares, 3.69% of the total portfolio. New Position

CVI Holdings, LLC initiated holding in NanoString Technologies Inc. The purchase prices were between $14.83 and $29.74, with an estimated average price of $22.81. The stock is now traded at around $28.06. The impact to a portfolio due to this purchase was 25.72%. The holding were 774,068 shares as of .

CVI Holdings, LLC initiated holding in Blueprint Medicines Corp. The purchase prices were between $48.7 and $86.6, with an estimated average price of $73.56. The stock is now traded at around $76.83. The impact to a portfolio due to this purchase was 22.23%. The holding were 200,000 shares as of .

CVI Holdings, LLC initiated holding in EyePoint Pharmaceuticals Inc. The purchase prices were between $1.77 and $2.72, with an estimated average price of $2.37. The stock is now traded at around $1.76. The impact to a portfolio due to this purchase was 3.69%. The holding were 1,484,714 shares as of .

CVI Holdings, LLC initiated holding in Aeglea BioTherapeutics Inc. The purchase prices were between $7.49 and $9.4, with an estimated average price of $8.33. The stock is now traded at around $6.74. The impact to a portfolio due to this purchase was 3.04%. The holding were 271,542 shares as of .

CVI Holdings, LLC initiated holding in Titan Medical Inc. The purchase prices were between $1.21 and $4.5, with an estimated average price of $3.26. The stock is now traded at around $2.59. The impact to a portfolio due to this purchase was 2.96%. The holding were 762,371 shares as of .

CVI Holdings, LLC initiated holding in vTv Therapeutics Inc. The purchase prices were between $1.67 and $3.12, with an estimated average price of $2.43. The stock is now traded at around $1.53. The impact to a portfolio due to this purchase was 2.92%. The holding were 1,229,153 shares as of .

CVI Holdings, LLC added to a holding in Axovant Gene Therapies Ltd by 73.94%. The purchase prices were between $7.68 and $14.16, with an estimated average price of $9.89. The stock is now traded at around $7.98. The impact to a portfolio due to this purchase was 4.82%. The holding were 767,300 shares as of .

CVI Holdings, LLC sold out a holding in Rexahn Pharmaceuticals Inc. The sale prices were between $6.12 and $16.56, with an estimated average price of $8.42.

CVI Holdings, LLC sold out a holding in VBI Vaccines Inc. The sale prices were between $1.54 and $2.01, with an estimated average price of $1.8.

CVI Holdings, LLC sold out a holding in Aerpio Pharmaceuticals Inc. The sale prices were between $0.9 and $4.25, with an estimated average price of $2.86.

CVI Holdings, LLC sold out a holding in China Recycling Energy Corp. The sale prices were between $0.71 and $1.42, with an estimated average price of $0.97.

CVI Holdings, LLC sold out a holding in Sonoma Pharmaceuticals Inc. The sale prices were between $0.7 and $1.08, with an estimated average price of $0.84.

CVI Holdings, LLC sold out a holding in Phio Pharmaceuticals Corp. The sale prices were between $0.24 and $0.43, with an estimated average price of $0.32.